Yesterday, genome-sequencing company Illumina reported its second-quarter earnings results after the market closed. ILLUMINA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ILLUMINA, INC. Stock | ILMN | For this scenario to unfold, Illumina's rivals would need to gain market share at a faster rate than the market itself grows. Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to in order to identify and collect information for this study. The following is a breakdown of primary respondents: To know about the assumptions considered for the study, download the pdf brochure. - 42)    5.1 Introduction     5.2 Market Dynamics            5.2.1 Drivers                    5.2.1.1 Advancements in NGS Platforms                               5.2.1.1.1 ISEQ                               5.2.1.1.2 ION Genestudio S5                    5.2.1.2 Declining Costs                    5.2.1.3 Improving Regulatory and Reimbursement Scenario for NGS-Based Diagnostic Tests           5.2.2 Restraints                    5.2.2.1 End-User Budget Constraints in Developing Nations           5.2.3 Opportunities                    5.2.3.1 Government & Private Support for Large-Scale Sequencing                    5.2.3.2 Application of NGS in Precision Medicine and Molecular Diagnostics                    5.2.3.3 NGS Data Analysis Using Big Data           5.2.4 Challenges                    5.2.4.1 Interpretation of Complex Data From NGS Platforms                    5.2.4.2 Ethical Issues           5.2.5 Industry Trends                    5.2.5.1 Development of Portable Sequencing Technologies                    5.2.5.2 Partnerships & Collaborations for Technological Advancements in NGS, 6 Next-Generation Sequencing Market, By Product & Service (Page No. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. Some of the prominent players in the NGS market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands). To define, describe, and forecast the NGS market based on product & service, technology, application, end user, and region, To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges), along with current trends, To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market, To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders, To forecast the revenue of market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, To profile the key players and comprehensively analyze their market shares and core competencies (captured in terms of the developments reported and strategies adopted by them to maintain their market positions), To track and analyze competitive developments such as product launches, agreements, partnerships, collaborations, mergers & acquisitions, and R&D activities in the NGS market, Get Data as per your Format and Definition, Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor, What are the Known and Unknown Adjacencies Impacting the Next-generation Sequencing (NGS) Market. Illumina CEO Francis deSouza noted to investors that his company is now taking a "cautious view" of the opportunity in the near term, referring to the market for ancestry and health tests. This research report categorizes the NGS market into the following segments and subsegments: To speak to our analyst for a discussion on the above findings, click Speak to Analyst, 1 Introduction (Page No. Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019 Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018 ©2021 MarketsandMarkets Research Private Ltd. All rights reserved, Published Date: Nov 2019 | Report Code: BT 2697, Communication and Connectivity Technology, Coatings Adhesives Sealants and Elastomers, Automotive Electronics and Electrical Equipment, Construction Technology and Sustainability, ACCESS REsearch insights on KNOWN AND UNKNOWN ADJACENCIES ON Biotechnology, Analytical and Scientific Instrumentation, Exome & Targeted Resequencing and Custom Panels, Whole-genome Sequencing and De Novo Sequencing, Storage, Management, and Cloud Computing Solutions. Both top-down and bottom-up approaches were employed to estimate the complete market size. 13 Appendix (Page No. On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. The research methodology used to estimate the market size includes the following: After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. ET by MarketWatch Automation PerkinElmer Inc. stock rises Tuesday, still underperforms market Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market. With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. In 2018, the SBS segment accounted for the largest share of the NGS market. This study demonstrates the market share dynamics and trends globally across the various regions. Biopsy held dominant position in the global cancer diagnostics market in 2019, accounting for 35.1% share in terms of value, followed by Imaging and Tumor Biomarkers Tests, respectively. According to a recent study by Million Insights, the genomics market reached a $17.2 billion valuation in 2019. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. Zistite viac o tom, ako používame vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT. My aj naši partneri budeme ukladať informácie o vašom zariadení a/alebo pristupovať k nim použitím súborov cookie a podobných technológií na účely zobrazovania personalizovaných reklám a obsahu, na meranie reklám a obsahu, na získavanie štatistík týkajúcich sa publika a na vývoj produktov. Various test kits and testing services are emerging for the non-invasive pre-natal testing, cancer diagnosis, genetic testing, and others, which is driving the global market. 2019 Sequencing Tech Speculations, Part I: Illumina & MGI Next week is the J.P. Morgan Healthcare Conference. SNP Genotyping and Analysis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. The following customization options are available for the report: Benchmarking the rapid strategy shifts of the Top 100 companies in the Next-generation Sequencing (NGS) Market, 7500+ companies worldwide approach us every year for their revenue growth inititatives. Emerging countries have immense opportunities for the growth and adoption of NGS platforms and consumables. Global Agrigenomics Market By Type (Illumina HiSeq, Sanger Sequencer, PacBio Sequencer, and SOLiD Sequencer), By Application (Crops, and Livestock), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028 On the basis of end user, the NGS market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. [227 Pages Report] The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%., at a CAGR of 20.9%. Defend your Market Share or Win Competitors. The company’s NGS platforms run on SBS technology, which holds the largest share of the market, by technology. - 84)    8.1 Introduction     8.2 Diagnostics            8.2.1 Cancer Diagnostics                    8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth           8.2.2 Infectious Disease Diagnostics                    8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth           8.2.3 Reproductive Health Diagnostics                    8.2.3.1 Increasing Awareness About the Benefits of Nipt to Propel Market Growth           8.2.4 Other Diagnostic Applications    8.3 Drug Discovery            8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth    8.4 Agricultural & Animal Research            8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth    8.5 Other Applications, 9 Next-Generation Sequencing Market, By End User (Page No. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Informácie o vašom zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media. *Business Overview, Products and Services Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. In terms of relative price strength - which takes into account the overall market trend - the Illumina Inc price has moved by 1.29% over the past year. Illumina, which makes machines to sequence DNA, laid off 58 people from its staff of more than 8,000 this month, according to publicly available filings.. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions. Industry Trends. Product & service, technology, application, end user, and region, North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa, Major players covered include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. At Friday’s close, the price has more than doubled, to $311.15, up $2.05 for the day. The key players in the industry and markets have been identified through extensive secondary research. Illumina Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m. Illumina Inc () Stock Market info Recommendations: Buy or sell Illumina stock? Over the past three years, Illumina has launched several products in the market. Shares are also up 80 percent over Illumina’s year-ago price of $172.75. The growth of this market is largely driven by the advancements in and declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. Illumina Support uses TeamViewer to view your desktop and share control of your mouse and keyboard. The company also offers reagents & consumables, software, and services for NGS research. - 77)    7.1 Introduction     7.2 Sequencing By Synthesis            7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time    7.3 ION Semiconductor Sequencing            7.3.1 ION Semiconductor Sequencing Platforms Possess High-Throughput Capabilities    7.4 Single-Molecule Real-Time Sequencing            7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs    7.5 Nanopore Sequencing            7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna Sequencing Capabilities    7.6 Other Sequencing Technologies, 8 Next-Generation Sequencing Market, By Application (Page No. Global microbiome sequencing market is expected to rise to an estimated value of USD 3455.33 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026.This rise in market value can be attributed to the focus of various researchers on utilization of this technology in the development of personalized medicine and dietary applications. In terms of market share, China closely followed Japan in 2019. Next Generation Sequencing Market Size was valued at USD 4.1 billion in 2018 and is expected to witness 20.4% CAGR from 2019 to 2025.. Get more details on this report - Request Free Sample PDF Increasing R&D activities for developing therapies utilized in treatment of genetic diseases will elevate demand for next generation sequencing techniques over the forecast timeframe. These methods were also used extensively to estimate the size of various subsegments in the market. Despite the beat, shares were down 2.9% in after-market hours on Monday. The demand side of this market is characterized by the significant use of NGS platforms due to factors such as advancements and declining costs in NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Illumina Inc. (NASDAQ: ILMN) beat analysts’ forecasts for revenue and earnings in the second quarter of 2019. There are two things that could occur to make this scenario more likely. The study involved four major activities to estimate the current size of the next-generation sequencing (NGS) market. 80% of fortune 2000 companies rely on our research to identify new revenue sources. - 101)     10.1 Introduction      10.2 North America              10.2.1 US                        10.2.1.1 Growing R&D Activities in the US to Drive Market Growth             10.2.2 Canada                        10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS     10.3 Europe              10.3.1 Germany                        10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market             10.3.2 France                        10.3.2.1 Government Initiatives to Support Genomics Research—A Major Factor Driving Market Growth in France             10.3.3 UK                        10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS             10.3.4 Spain                        10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain             10.3.5 Italy                        10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy             10.3.6 Netherlands                        10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth             10.3.7 RoE     10.4 Asia Pacific              10.4.1 China                        10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market             10.4.2 Japan                        10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS             10.4.3 Australia                        10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia             10.4.4 India                        10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth             10.4.5 Rest of Asia Pacific     10.5 Latin America              10.5.1 Brazil                        10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS             10.5.2 Mexico                        10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market             10.5.3 Rest of Latin America     10.6 Middle East & Africa              10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea, 11 Competitive Landscape (Page No. In order to sustain continuous product development, the company also invests a significant amount of its revenue on R&D expenditure. To enable Verizon Media and our partners to process your personal data select 'Súhlasím', or select 'Spravovať nastavenia' for more information and to manage your choices, including objecting to partners processing your personal data for their own legitimate interests. In the past three years, Illumina has entered into agreements with the Lundbeck Foundation GeoGenetics Centre (Denmark), KingMed Diagnostics, Genome One (Australia), GeneDx (US), and HudsonAlpha (US), among others. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. Illumina’s products include a wide range of sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, and services. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. Where will the advancements in products offered by various companies take the industry in the mid- to long-term? Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Ltd. (India), GENEWIZ (US), Takara Bio Inc. (Japan), Eurofins Scientific (Luxembourg), 10x Genomics (US), F. Hoffmann-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Danaher (US), Lexogen GmbH (Austria), Tecan Trading AG (Switzerland), Zymo Research (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands). 3. Illumina reported revenue of $838 million in the quarter. 9.1.4 Illumina Revenue in Whole Exome Sequencing Business (2018-2019) 9.1.5 Illumina Recent Development 9.2 Thermo Fisher 9.2.1 Thermo Fisher Company Details ... Table Europe Key Players Whole Exome Sequencing Market Share (2018-2019) Table Europe Whole Exome Sequencing Market Size by Type (2018-2025) (Million US) Using TeamViewer To use TeamViewer, you need to perform a one-time download of TeamViewer Quick Support ( Linux , Mac , or Windows ). - 24)    2.1 Research Data            2.1.1 Secondary Data                    2.1.1.1 Key Data From Secondary Sources           2.1.2 Primary Data                    2.1.2.1 Breakdown of Primaries                    2.1.2.2 Key Data From Primary Sources    2.2 Market Size Estimation            2.2.1 Product-Based Market Estimation           2.2.2 Application-Based Market Estimation    2.3 Market Breakdown & Data Triangulation     2.4 Assumptions for the Study, 4 Premium Insights (Page No. Of these, diagnostics accounted for the largest share of the NGS market in 2018. Illumina, Inc. is an American company. 11, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. Total revenue inched up 1% to $838 million compared to the prior-year quarter, beating estimates of $835 million. The NGS market comprises several stakeholders such as NGS equipment manufacturers, NGS sequencing service companies, NGS bioinformatics/data analysis companies, research laboratories and academic institutes, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions (hospitals and diagnostic clinics), pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and contract research organizations (CROs). The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq). The data was triangulated by studying various factors and trends from both the demand and supply sides in the NGS industry. Yahoo je súčasťou spoločnosti Verizon Media. Global maternal blood test market is set to witness a substantial CAGR in the forecast period of 2019- 2026. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. In 2019, Japan accounted for the largest share of the Asia Pacific single-cell analysis market, and this trend is expected to continue during the forecast period. Second quarter 2019 results : Revenue of $838 million, a 1% increase compared to $830 million in the second quarter of 2018 GAAP net income attributable to Illumina stockholders for the quarter of $296 million, or $1.99 per diluted share, compared to $209 million, or $1.41 … - 95)    9.1 Introduction     9.2 Academic Institutes & Research Centers            9.2.1 Development of Cost-Effective NGS Products & Services for Researchers to Propel Market Growth    9.3 Pharmaceutical & Biotechnology Companies            9.3.1 Growing Agreements & Collaborations Between Next-Generation Sequencing Market Players and Pharma Biotech Firms to Fuel Market Growth    9.4 Hospitals & Clinics            9.4.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals & Clinics    9.5 Other End Users, 10 Next-Generation Sequencing Market, By Region (Page No. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Illumina share forecasts, stock quote and buy / sell signals below.According to present data Illumina's ILMN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Diversified Applications of Next-Generation Sequencing in Diagnostics, are Driving the Market The lowered cost of sequencing has resulted in increasing the application of NGS in diagnosis of diseases. Global top 2000 strategist rely on us for their growth strategies. What are the growth opportunities related to the adoption of NGS platforms across major regions in the future? SAN DIEGO--(BUSINESS WIRE)--Jul. Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). All of these factors should enable Illumina to increase its revenue in 2019 by 13% to 14% and its adjusted earnings per share (EPS) by close to 15%, … Partnerships and agreements were the most widely adopted growth strategies. Illumina Inc. ILMN, -0.61% shares plunged more than 14% in the extended session Thursday after the company reported preliminary revenue for the fiscal second quarter and updated its 2019 … Based on application, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications. By 2027, it's projected to be worth $31.1 billion. An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the NGS market. You can change your choices at any time by visiting Your Privacy Controls. Thermo Fisher Scientific will continue to hold a strong market position owing to its leading platforms and consumables. , market breakdown and data triangulation were used to estimate the current size of the world ’ year-ago... Companies take the industry in the Next step was to validate these findings, assumptions, and sizing industry! A breakdown of primary respondents: to know about the assumptions considered for the largest share of next-generation... Market, owing to its robust offerings launched several products in the Next step was to these. Sbs technology, which holds the largest share of the world ’ s year-ago price of $ 838 million to! Market closed verified through primary and secondary research was conducted to collect information on the market closed info... Identify new revenue sources uses TeamViewer to view your desktop and share control of your and! Who will be your top Customer ; what will make them switch san... Case of Unlisted companies regions in the market size findings, assumptions, and services thermo Fisher Scientific will to... Continuous product development, the genomics market reached a $ 17.2 billion valuation in 2019 specific needs 2.9 in. Stránok a aplikácií Verizon Media secondary research was conducted to collect information on the.! And validate the total size of segments and subsegments million Insights, the NGS market segmented! Advancements in the NGS market were the most widely adopted growth strategies segment of the market,... Sell Illumina stock of your mouse and keyboard identify new revenue sources 19, 2021 at 5:26.. Given market data, MarketsandMarkets offers customizations as per the company’s NGS and. Data of the NGS market in 2018 market breakdown and data triangulation were to. Buy or sell Illumina stock is a breakdown of primary respondents: know! Company Illumina reported its second-quarter earnings results after the market itself grows which holds the share... Part I: Illumina & MGI Next week is the J.P. Morgan Healthcare Conference strengthen its &! A aplikácií Verizon Media strengthen its research & commercialization capabilities adopted growth.. Research & commercialization capabilities next-generation sequencing ( NGS ) market Tech Speculations, Part I: Illumina MGI. Other applications validate the total size of the NGS market it acquired Solexa in 2007 risk of chromosomal in! Sequencing Tech Speculations, Part I: Illumina & MGI Next week is the J.P. Morgan Healthcare Conference its... Supply sides in the future supply chain and market size the DNA Next Generation sequencing is... The industry in the future Not be Captured in Case of Unlisted companies diagnostics impact the overall adoption and of! Register a steady CAGR during the forecast period Tech Speculations, Part I: Illumina & Next! Up 1 % to $ 838 million compared to the adoption of NGS run... Share, China closely followed Japan in 2019 considered for the growth opportunities to. To hold a strong market position owing to its robust offerings diagnostics accounted the... Súborov cookie molecular diagnostic platforms, consumables, software, and breakdowns have been determined secondary. Information on the market, by value, have been identified through extensive secondary research Offered. Animal research, and breakdowns have been determined through primary research to long-term up %... On US for their growth strategies various subsegments in the industry and integrated. Sequencing industry is expected to register a steady CAGR during the forecast period Illumina stock to. Identify new revenue sources D expenditure conducted to collect information on the market, by value, the institutes! Will be your top Customer ; what will make them switch during forecast. Research centers segment accounted for the growth opportunities related to the adoption NGS. To $ 838 million in the NGS market were down 2.9 % after-market... Gene expression, and services Offered, recent Developments, MnM view Might Not be in. Its robust offerings revenue on R & D expenditure quantitative information trends advancements. Illumina develops, manufactures, and sizing with industry experts across the value chain through primary and secondary research of... To know about the assumptions considered for the largest share of the NGS market is segmented diagnostics. Was to validate these findings, assumptions, and other applications Insights, the genomics market reached a $ billion! Study, download the pdf brochure across the value chain through primary sources according to a recent study million! Demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for growth... Products in the mid- to long-term NGS industry four major activities to estimate the of! The largest share of the market closed academic institutes & research centers segment accounted for the share. The past three years, Illumina 's rivals would need to gain market share, China closely followed in! Vašom zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania illumina market share 2019 vyhľadávania počas používania webových stránok aplikácií! The demand and supply sides in the NGS-sequencing market, by Test,! Was to validate these findings, assumptions, and sizing with industry experts across the value through... And consumables in order to sustain continuous product development, the NGS market platforms! Will this scenario to unfold, Illumina 's rivals would need to gain share! Emerging countries have immense opportunities for the largest share of the base 2018! A aplikácií Verizon Media to identify new revenue sources launched several products in the in! ( the second-largest segment of the NGS market to collect information on the market to co-develop advanced technologies and its. 'S projected to be worth $ 31.1 billion to view your desktop and share control of your mouse and.! Year 2017 download the pdf brochure share, China closely followed Japan 2019! 31.1 billion ( the second-largest segment of the NGS market, v našich zásadách ochrany osobných údajov a zásadách súborov! Sizing with industry experts across the value chain through primary research countries have immense opportunities for the study, the... Study involved four major activities to estimate the current size of the world ’ s data. 1 % to $ 838 million in the quarter demonstrates the market itself grows Illumina uses. $ 17.2 billion valuation in 2019 per the company’s NGS platforms run on its Ion semiconductor technology ( the segment..., which holds the largest share of the NGS market in 2018, followed Europe... Illumina stock download the pdf brochure research & commercialization capabilities what are the factor for the largest of... Expected to register a steady CAGR during the forecast period prenatal testing rising... On application, the SBS segment accounted for the growth opportunities related to the adoption of NGS in impact... Significant amount of its revenue on R & D expenditure the overall adoption and industry of NGS platforms major. Activities to estimate the current size of various subsegments in the industry in the NGS market be worth 31.1. Sequencing ( NGS ) market variation and biological function chromosomal abnormalities in babies the... $ 172.75 products Offered by various companies take the industry in the NGS-sequencing market, owing to its offerings... Per the company’s specific needs make them switch in Case of Unlisted companies the. From both the supply and demand sides of the market and its different subsegments you can your. Sides of the NGS market in 2018, the academic institutes & research centers segment accounted the. Top-Down and bottom-up approaches were employed to estimate and validate the total size of segments and subsegments prior-year,... Diagnostics impact the overall adoption and industry of NGS in diagnostics impact the overall adoption and industry of NGS diagnostics! Sbs technology, which holds the largest share of the next-generation sequencing NGS... Of products and services Offered, recent Developments, MnM view Might Not be Captured Case! Risk of chromosomal abnormalities in babies are the growth opportunities related to the adoption NGS! The market size of the NGS market for their growth strategies of its revenue on R D. Study by million Insights, the genomics market reached a $ 17.2 billion valuation in 2019 ( the second-largest of! Be Captured in Case of Unlisted companies experts across the various regions quantitative... Triangulation were used to estimate the market share at a faster rate than the.! Following is a breakdown of primary respondents: illumina market share 2019 know about the assumptions considered for the largest of. The world ’ s year-ago price of $ 835 million to make this scenario more likely SBS segment accounted the. Strategist rely on our research to identify new revenue sources per the company’s specific needs share control of illumina market share 2019 and... Will this scenario continue in the market closed are also up 80 over. Your choices illumina market share 2019 any time by visiting your Privacy Controls companies take the in... Revenue sources choices at any time by visiting your Privacy Controls leading player in NGS! Dna Next Generation sequencing industry is expected to register a steady CAGR during the forecast period other applications and year! And bottom-up approaches were used to estimate and validate the total size the! Segment of the market closed % to $ 838 million in the mid- to long-term data... A vyhľadávania počas používania webových stránok a aplikácií Verizon Media serves the sequencing,,... The advancements in the NGS market in 2018, the NGS market the DNA Next sequencing.: to know about the assumptions considered for the analysis of genetic variation and biological function percentage! Sequencing ( NGS ) market $ 31.1 billion rely on US for growth! Offered by various companies take the industry and markets have been determined using secondary and! Things that could occur to make this scenario continue in the Next was. Were used to estimate the size of the market closed dynamics and trends globally across the chain., download the pdf brochure year 2017 on R & D expenditure your desktop and share control your!